Director of AI Optimization and Productization - R&D Data Science & Digital Health at Johnson & Johnson

High Wycombe, England, United Kingdom

Johnson & Johnson Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Pharmaceuticals, MedTechIndustries

Requirements

  • Advanced degree (PhD or Master’s) in Computer Science, Machine Learning, Biomedical Engineering, or a related field
  • Additional training or certification in MLOps, AI optimization, product life cycle management

Responsibilities

  • Collaborate with AI scientists in DSDH, R&D partners, and JJT to optimize AI models for large-scale training, inference performance, and their deployment in AI products
  • Guide and supervise the productization of AI models into applications deployed within R&D or clinical trials for discovery, biomarkers, and clinical endpoints
  • Oversee the use of enterprise MLOps frameworks within DSDH in close collaboration with JJT, following company best practices and frameworks and managing the life cycle of DSDH AI models
  • Actively model and plan for compute capacity across DSDH projects, in partnership with the DSDH Data Strategy & Platform team and JJT
  • Work closely with DSDH, JJT, therapeutic areas, functions, and senior stakeholders across the enterprise to promote cross-functional collaboration and stakeholder engagement
  • Attract, grow, and lead a high-performing technical team focused on AI optimization, productization, and life cycle management
  • Mentor junior team members and foster a culture of continuous learning

Skills

AI
Machine Learning
Model Optimization
AI Deployment
Productization
Data Science
Digital Health

Johnson & Johnson

Healthcare products in pharmaceuticals and devices.

About Johnson & Johnson

Johnson & Johnson operates in the healthcare sector with three main areas: pharmaceuticals, medical devices, and consumer health products. In the pharmaceuticals segment, the company develops prescription drugs for various medical conditions such as cancer and infectious diseases. The medical devices segment provides products used in surgeries and other medical procedures, while the consumer health segment offers over-the-counter products, including baby care and personal health items. Johnson & Johnson generates revenue through direct sales and partnerships, and it invests significantly in research and development to create new products that meet the needs of consumers and healthcare providers. The company stands out from competitors by emphasizing diversity, equity, and inclusion in its workplace, fostering an environment where employees can share their perspectives. Its goal is to improve patient outcomes and enhance the overall health and well-being of individuals globally.

New Brunswick, New JerseyHeadquarters
1886Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Risks

J&J faces a class action lawsuit in Australia over ineffective cold and flu medications.
Former J&J executives joining other firms could lead to increased competition.
Ongoing legal battles, like the lawsuit against Cigna, pose financial liabilities for J&J.

Differentiation

J&J operates in three segments: pharmaceuticals, medical devices, and consumer health.
The company invests heavily in R&D for innovative medical solutions and products.
J&J is committed to diversity, equity, and inclusion in its workplace culture.

Upsides

J&J's collaboration with Helsinki University Hospital focuses on value-based healthcare models.
The rise of personalized medicine offers J&J opportunities in targeted therapies.
Increased focus on digital health solutions presents expansion opportunities for J&J.

Land your dream remote job 3x faster with AI